Comparison between Tatva Chintan Pharma Chem IPO and Zomato IPO.
Tatva Chintan Pharma Chem IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Zomato IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Tatva Chintan Pharma Chem IPO is up to ₹500.00 Cr whereas the issue size of the Zomato IPO is up to ₹9,375.00 Cr. The final issue price of Tatva Chintan Pharma Chem IPO is ₹1,083.00 per share and of Zomato IPO is ₹76.00 per share.
| Tatva Chintan Pharma Chem IPO | Zomato IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ₹1,073.00 per share | ₹72.00 per share |
| Issue Price (Upper) | ₹1,083.00 per share | ₹76.00 per share |
| Issue Price (Final) | ₹1,083.00 per share | ₹76.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 13 shares | 195 shares |
| Fresh Issue Size | 20,77,562 shares | 1,18,42,10,526 shares |
| Fresh Issue Size (Amount) | up to ₹225.00 Cr | up to ₹9,000.00 Cr |
| OFS Issue Size | 25,39,242 shares | 4,93,42,105 shares |
| OFS Issue Size (Amount) | up to ₹275.00 Cr | up to ₹375.00 Cr |
| Issue Size Total | 46,16,804 shares | 1,23,35,52,631 shares |
| Issue Size Total (Amount) | up to ₹500.00 Cr | up to ₹9,375.00 Cr |
Tatva Chintan Pharma Chem IPO opens on Jul 16, 2021, while Zomato IPO opens on Jul 14, 2021. The closing date of Tatva Chintan Pharma Chem IPO and Zomato IPO is Jul 20, 2021, and Jul 16, 2021, respectively.
| Tatva Chintan Pharma Chem IPO | Zomato IPO | |
|---|---|---|
| Anchor Bid Date | Jul 15, 2021 | Jul 13, 2021 |
| Issue Open | Jul 16, 2021 | Jul 14, 2021 |
| Issue Close | Jul 20, 2021 | Jul 16, 2021 |
| Basis Of Allotment (Tentative) | Jul 26, 2021 | Jul 22, 2021 |
| Initiation of Refunds (Tentative) | Jul 27, 2021 | Jul 23, 2021 |
| Credit of Share (Tentative) | Jul 28, 2021 | Jul 23, 2021 |
| Listing date (Tentative) | Jul 29, 2021 | Jul 23, 2021 |
| Anchor Lockin End date 1 | Aug 25, 2021 | Aug 21, 2021 |
| Anchor Lockin End date 2 | Oct 24, 2021 | Oct 20, 2021 |
Tatva Chintan Pharma Chem IPO P/E ratio is , as compared to Zomato IPO P/E ratio of .
| Tatva Chintan Pharma Chem IPO | Zomato IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 100 | |||||
| Promoter Shareholding (Post-Issue) | 79.17 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2400.48 Cr. | ₹59623.37 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Tatva Chintan Pharma Chem IPO Retail Individual Investors (RII) are offered 16,15,882 shares while in Zomato IPO retail investors are offered 16,15,882 shares. Qualified Institutional Buyers (QIB) are offered 9,23,361 shares in Tatva Chintan Pharma Chem IPO and 36,81,15,969 shares in Zomato IPO.
| Tatva Chintan Pharma Chem IPO | Zomato IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,85,040 shares | 55,21,73,505 shares |
| Market Maker Reservation | ||
| QIB | 9,23,361 shares | 36,81,15,969 shares |
| NII | 6,92,521 shares | 18,40,57,894 shares |
| RII | 16,15,882 shares | 12,27,05,263 shares |
| Employee | 65,00,000 shares | |
| Others | ||
| Total | 46,16,804 shares | 1,23,35,52,631 shares |
Tatva Chintan Pharma Chem IPO subscribed 180.36x in total, whereas Zomato IPO subscribed 38.25x.
| Tatva Chintan Pharma Chem IPO | Zomato IPO | |
|---|---|---|
| QIB (times) | 185.23x | 51.79x |
| NII (times) | 512.22x | 32.96x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 35.35x | 7.45x |
| Employee (times) | 0.62x | |
| Other (times) | ||
| Total (times) | 180.36x | 38.25x |
